Home / Health / Shingles Vaccine Linked to Healthier Aging
Shingles Vaccine Linked to Healthier Aging
21 Jan
Summary
- Shingles vaccination is associated with reduced biological aging signs.
- Vaccinated individuals showed less inflammation and slower aging.
- The vaccine may support healthier aging by reducing inflammation.
A recent study involving over 3,800 individuals indicates that the shingles vaccination may contribute to healthier aging. The research observed that vaccinated participants showed diminished signs of biological aging and inflammation.
These findings suggest that the vaccine could potentially slow age-related decline by reducing background inflammation. This mechanism might be linked to preventing the reactivation of the virus that causes shingles.
The study measured seven aspects of biological aging, including inflammation, immune response, and epigenetic aging. Participants who received the shingles jab demonstrated significantly lower inflammation levels and slower epigenetic and transcriptomic aging.
These results align with emerging evidence connecting adult vaccines, such as those for shingles and influenza, with reduced risks of dementia and neurodegenerative disorders. The research highlights the potential for vaccines to modulate biological systems beyond merely preventing infection, thereby promoting resilience and supporting healthy aging strategies.
